Market Strategies to Consider Amid MemoryChip Rally Fueled by Micron Consumer Price Index Rises 38 YearoverYear in April Marking Fastest Pace Since May 2023 Walmart May Use Tariff Refunds to Lower Prices Amid Consumer Stress ONGC Q4FY26 Net Profit Rises 3 to 6650 Crore Declares Final Dividend Amid Production Declines Amazon Expands AI Shopping Technology to Retailers with Kate Spade as First Customer Standard Chartered CEO Apologizes for Lower Value Human Capital Remark Saul Centers Inc BFS Q1 2026 Earnings EPS Surges 98 Above Estimates Stock Modestly Higher NSP Q1 2026 Earnings Earnings Beat Estimates Amidst Operational Challenges Outset Medical Inc OM Q1 2026 Earnings EPS Misses Estimates Amid Operational Challenges IAC Q1 2026 Earnings EPS Falls Sharply Short of Estimates Stock Rises 21 MPLX Q1 2026 Earnings EPS Misses Estimates by 156 as Midstream Operations Face Headwinds CPK Q1 2026 Earnings Earnings Beat Estimates Amidst Operational Strength Adecoagro AGRO Shares Slide Nearly 6 as Commodity Price Headwinds Intensify Generac GNRC Surges Over 9 as Renewed Demand Optimism Drives Powerful Rally Brazil Potash Corp GRO Holds Steady at 250 as Traders Eye Key Levels Jazz Pharmaceuticals JAZZ Experiences Modest Decline Following Recent RunUp Zentek Ltd ZTEK Faces Selling Pressure as Shares Decline Over 8 Kazatomprom Reports 17 Production Surge in Q3 Amid Nuclear Energy Momentum ABBV Q1 2026 Earnings Modest EPS Beat Amidst Market Stability IonQ IONQ Surges 28 as Quantum Computing Stock Tests Key Resistance Reliance Global Group Q1 2023 Earnings Surprise Profitability Defies Estimates INTR Q1 2026 Earnings EPS Misses Expectations Despite Positive Stock Movement Gartner IT Q1 2026 Earnings Strong EPS Beat Signals Resilient Tech Demand NCS Multistage Holdings Inc NCSM Q1 2026 Earnings EPS Misses Estimates Significantly Revenue Data Unavailable SMTC Q1 2026 Earnings EPS Surges 106 Above Estimates Yet Stock Slides 44 East West Bancorp Inc EWBC Q1 2026 Earnings EPS Beats Estimates Stock Holds Steady RNTX Q1 2026 Earnings EPS Beats Estimates as Preclinical Stage Biotech Tightens Spending